Sharing my story helps raise awareness about pulmonary fibrosis
For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey.| Pulmonary Fibrosis News
For columnist Sam Kirton, Pulmonary Fibrosis Awareness Month is an opportunity to tell others about his journey.| Pulmonary Fibrosis News
GRI-0621, an experimental oral therapy for IPF, may stabilize lung function, according to an interim analysis of an ongoing trial.| Pulmonary Fibrosis News
Columnist Sam Kirton talks to Scott Staszak, president and CEO of the Pulmonary Fibrosis Foundation, about the need for better research.| Pulmonary Fibrosis News
September is Pulmonary Fibrosis Awareness Month, and advocates are hoping to call attention to the condition and interstitial lung diseases.| Pulmonary Fibrosis News
Columnist Sam Kirton takes readers on his journey from a pulmonary function test to his results from lung biopsies that weren't routine.| Pulmonary Fibrosis News
There are more immune NK T-cells in the lungs of people with idiopathic pulmonary fibrosis than in healthy people, research shows| Pulmonary Fibrosis News
Columnist Sam Kirton finds that filling the silence is part of living with a chronic condition, especially amid retirement and COVID-19.| Pulmonary Fibrosis News
Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.| Pulmonary Hypertension News
Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic pulmonary fibrosis.| Pulmonary Fibrosis News
IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for reversing scarring.| Pulmonary Fibrosis News
Read about the different factors that can cause pulmonary fibrosis.| Pulmonary Fibrosis News
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.| Pulmonary Fibrosis News
A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study found.| Pulmonary Hypertension News
An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded orphan drug status.| Pulmonary Fibrosis News
Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.| Pulmonary Fibrosis News
Pulmonary hypertension (PH) is a chronic and progressive disease associated with high blood pressure in the blood vessels that supply the lungs, known as the pulmonary arteries. Read more about PH here.| Pulmonary Hypertension News
